Delivery Order SPE2DB22D3501-SPE2DB25FTN25
Award Date
11/18/24
Potential Completion Date
12/10/24
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,976.65, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,953.30, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 27, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award, valued at $4,651.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract is a Firm Fixed Price Delivery Order with a performance period extending through May 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,974.10 firm-fixed-price delivery order is for the supply of LEQVIO 284 MG/1.5 ML syringes. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities to...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is valued at $21,974.10 and runs through February 23, 2024. It involves the delivery of the specialty pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML to support military treatment programs and facilities. Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract has a ceiling value of $6,976.65 and is a firm fixed price delivery order with a completion date of June 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the procurement of Leqvio 284 mg/1.5 ml syringes. The Firm Fixed Price contract, valued at $21,974.10, has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,640.10 firm fixed price delivery order is for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML" with a completion date of January 10, 2025. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a firm fixed price and a ceiling value of $13,953.30, with a performance period through May 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract is a Delivery Order with a Firm Fixed Price of $2,197.41 and an Ultimate Completion Date of June 28, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for providing logistics, acquisition, and technical services to the...